Patents Assigned to HRAIN BIOTECHNOLOGY CO., LTD.
  • Anti-human MSLN antibody and MSLN-targeting immune effector cell
    Patent number: 11957717
    Abstract: The present invention provides an anti-human MSLN-specific antibody and an MSLN-targeting immune effector cell. Also provided is an MSLN-targeting chimeric antigen receptor modified T-cell prepared using the antibody and a use thereof.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: April 16, 2024
    Assignee: HRAIN BIOTECHNOLOGY CO., LTD.
    Inventors: Fei Huang, Tao Peng, Xuemei Zou, Pinglei Liu, Dachun Liu, Hui Huang